Skip to main content
. 2021 Mar 23;22:106. doi: 10.1186/s12882-021-02312-2

Table 3.

Overview of all adverse events reported during the trial (1 year follow up)

Description Cinacalcet No of patients (no of events) Control No of patients (no of events) Details of events p-Value
Infection 2 (3) 6 (7) 0.43
Renal transplant 1 2 (2) 0.7
Vascular access procedures 4 (11) 1 0.06
Death 1 brain tumour 0.4
Parathyroidectomy 1 0.4
Low calcium 11 (20) 4 (5) < 2.1 mmol/L 0.01
High calcium 2 (5) 9 (17) > 2.6 mmol/L 0.06
Claustrophobia 3 1 In MR scan 0.4
Other 11 (16) 12 (20) 0.4